Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirban P Mitra

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Therapeutic Advances in Urology|June 2, 2016
Molecular substratification of bladder cancer: moving towards individualized patient managementAnirban P Mitra
The Journal of Urology|January 9, 2024
Editorial CommentAnirban P Mitra
Idrugs : the Investigational Drugs Journal|June 12, 2009
American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USAAnirban P Mitra
Cancer Treatment and Research|September 1, 2018
Molecular Prognostication in Bladder CancerAnirban P Mitra, Siamak Daneshmand
Urologic Oncology|July 14, 2007
Searching for novel therapeutics and targets: insights from clinical trialsAnirban P Mitra, Richard J Cote
Annual Review of Pathology|October 9, 2008
Molecular pathogenesis and diagnostics of bladder cancerAnirban P Mitra, Richard J Cote
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available AssaysJohn R Heard, Anirban P Mitra
Expert Review of Anticancer Therapy|June 29, 2011
Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?Anirban P Mitra, Richard J Cote
Nature Reviews. Urology|January 12, 2010
Molecular screening for bladder cancer: progress and potentialAnirban P Mitra, Richard J Cote
The Urologic Clinics of North America|April 18, 2015
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyondAnirban P Mitra, Seth P Lerner
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Urology|June 2, 2016
Molecular substratification of bladder cancer: moving towards individualized patient managementAnirban P Mitra
The Journal of Urology|January 9, 2024
Editorial CommentAnirban P Mitra
Idrugs : the Investigational Drugs Journal|June 12, 2009
American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USAAnirban P Mitra
Cancer Treatment and Research|September 1, 2018
Molecular Prognostication in Bladder CancerAnirban P Mitra, Siamak Daneshmand
Urologic Oncology|July 14, 2007
Searching for novel therapeutics and targets: insights from clinical trialsAnirban P Mitra, Richard J Cote
Annual Review of Pathology|October 9, 2008
Molecular pathogenesis and diagnostics of bladder cancerAnirban P Mitra, Richard J Cote
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available AssaysJohn R Heard, Anirban P Mitra
Expert Review of Anticancer Therapy|June 29, 2011
Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?Anirban P Mitra, Richard J Cote
Nature Reviews. Urology|January 12, 2010
Molecular screening for bladder cancer: progress and potentialAnirban P Mitra, Richard J Cote
The Urologic Clinics of North America|April 18, 2015
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyondAnirban P Mitra, Seth P Lerner
Pageof 7